BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 18068975)

  • 1. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
    Magesh S; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
    Bioorg Med Chem Lett; 2008 Jan; 18(2):532-7. PubMed ID: 18068975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors.
    Magesh S; Suzuki T; Miyagi T; Ishida H; Kiso M
    J Mol Graph Model; 2006 Oct; 25(2):196-207. PubMed ID: 16427342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2.
    Khedri Z; Li Y; Cao H; Qu J; Yu H; Muthana MM; Chen X
    Org Biomol Chem; 2012 Aug; 10(30):6112-20. PubMed ID: 22641268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human sialidase inhibitors: design, synthesis, and biological evaluation of 4-acetamido-5-acylamido-2-fluoro benzoic acids.
    Magesh S; Savita V; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
    Bioorg Med Chem; 2009 Jul; 17(13):4595-603. PubMed ID: 19450982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.
    Hyun SW; Liu A; Liu Z; Cross AS; Verceles AC; Magesh S; Kommagalla Y; Kona C; Ando H; Luzina IG; Atamas SP; Piepenbrink KH; Sundberg EJ; Guang W; Ishida H; Lillehoj EP; Goldblum SE
    Glycobiology; 2016 Aug; 26(8):834-49. PubMed ID: 27226251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues.
    Zhang Y; Albohy A; Zou Y; Smutova V; Pshezhetsky AV; Cairo CW
    J Med Chem; 2013 Apr; 56(7):2948-58. PubMed ID: 23530623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages.
    Stamatos NM; Liang F; Nan X; Landry K; Cross AS; Wang LX; Pshezhetsky AV
    FEBS J; 2005 May; 272(10):2545-56. PubMed ID: 15885103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogues structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
    Ikeda K; Sato K; Kitani S; Suzuki T; Maki N; Suzuki Y; Sato M
    Bioorg Med Chem; 2006 Dec; 14(23):7893-7. PubMed ID: 16908163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialidase expression in activated human T lymphocytes influences production of IFN-gamma.
    Nan X; Carubelli I; Stamatos NM
    J Leukoc Biol; 2007 Jan; 81(1):284-96. PubMed ID: 17028199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogs structurally modified by thiocarbamoylalkyl groups at the C-4 position: Synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
    Ikeda K; Sato K; Nishino R; Aoyama S; Suzuki T; Sato M
    Bioorg Med Chem; 2008 Jul; 16(14):6783-8. PubMed ID: 18555688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity.
    Tindal DJ; Dyason JC; Thomson RJ; Suzuki T; Ueyama H; Kuwahara Y; Maki N; Suzuki Y; von Itzstein M
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1655-8. PubMed ID: 17236768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of N-acetyl-6-sulfo-beta-d-glucosaminide-based inhibitors of influenza virus sialidase.
    Sasaki K; Nishida Y; Kambara M; Uzawa H; Takahashi T; Suzuki T; Suzuki Y; Kobayashi K
    Bioorg Med Chem; 2004 Mar; 12(6):1367-75. PubMed ID: 15018909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility.
    Rudrawar S; Kerry PS; Rameix-Welti MA; Maggioni A; Dyason JC; Rose FJ; van der Werf S; Thomson RJ; Naffakh N; Russell RJ; von Itzstein M
    Org Biomol Chem; 2012 Nov; 10(43):8628-39. PubMed ID: 22976385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors.
    Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
    Bioorg Med Chem; 2008 Apr; 16(7):3839-47. PubMed ID: 18304821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Inhibitors of Human Neuraminidase 1 (NEU1).
    Guo T; Héon-Roberts R; Zou C; Zheng R; Pshezhetsky AV; Cairo CW
    J Med Chem; 2018 Dec; 61(24):11261-11279. PubMed ID: 30457869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Effect of Neuraminidase-1-Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis.
    Luzina IG; Lillehoj EP; Lockatell V; Hyun SW; Lugkey KN; Imamura A; Ishida H; Cairo CW; Atamas SP; Goldblum SE
    J Pharmacol Exp Ther; 2021 Jan; 376(1):136-146. PubMed ID: 33139318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of a fluorous protecting group and its application to the chemoenzymatic synthesis of sialidase inhibitor.
    Ikeda K; Mori H; Sato M
    Chem Commun (Camb); 2006 Aug; (29):3093-4. PubMed ID: 16855696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
    Arioka S; Sakagami M; Uematsu R; Yamaguchi H; Togame H; Takemoto H; Hinou H; Nishimura S
    Bioorg Med Chem; 2010 Feb; 18(4):1633-40. PubMed ID: 20097567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sialidase mutant displaying trans-sialidase activity.
    Paris G; Ratier L; Amaya MF; Nguyen T; Alzari PM; Frasch AC
    J Mol Biol; 2005 Jan; 345(4):923-34. PubMed ID: 15588836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent.
    Atigadda VR; Brouillette WJ; Duarte F; Ali SM; Babu YS; Bantia S; Chand P; Chu N; Montgomery JA; Walsh DA; Sudbeck EA; Finley J; Luo M; Air GM; Laver GW
    J Med Chem; 1999 Jul; 42(13):2332-43. PubMed ID: 10395473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.